The Secret Behind CAS 10009-20-8: N-6-Trifluoroacetyl-L-Lysine's Health Benefits Explained

December 6, 2024

Abstract

This article delves into the health benefits of N-6-Trifluoroacetyl-L-Lysine, a compound with the CAS number 10009-20-8. Known for its unique structure and potential therapeutic applications, this amino acid derivative has garnered significant attention in the scientific community. The article explores six key aspects of its health benefits, including its role in protein synthesis, immune system support, and potential applications in cancer treatment, among others.

Introduction to N-6-Trifluoroacetyl-L-Lysine

N-6-Trifluoroacetyl-L-Lysine, or CAS 10009-20-8, is a derivative of the amino acid lysine, which is an essential building block of proteins. This compound has a trifluoroacetyl group attached to the amino group of lysine, giving it a unique structure that sets it apart from other lysine derivatives. Its potential health benefits have been a subject of extensive research, making it a promising candidate for various therapeutic applications.

Role in Protein Synthesis

One of the primary functions of lysine is its involvement in protein synthesis. N-6-Trifluoroacetyl-L-Lysine, being a derivative of lysine, also plays a crucial role in this process. It is incorporated into proteins during translation, where it contributes to the formation of peptide bonds. This unique amino acid derivative may enhance protein synthesis, potentially leading to improved muscle growth and repair.

Immune System Support

The immune system is a complex network of cells and proteins that work together to protect the body against pathogens. N-6-Trifluoroacetyl-L-Lysine has been shown to have immunomodulatory properties, meaning it can influence the function of the immune system. Studies suggest that it may enhance immune response, making it a potential therapeutic agent for conditions characterized by weakened immune function.

Potential Applications in Cancer Treatment

Cancer is a complex disease that affects millions of people worldwide. N-6-Trifluoroacetyl-L-Lysine has shown promise in cancer treatment due to its ability to inhibit the growth of cancer cells. Research indicates that it may interfere with the signaling pathways that promote cancer cell proliferation and survival. This makes it a potential candidate for developing novel cancer therapies.

Antioxidant Properties

Oxidative stress, caused by the accumulation of reactive oxygen species, is a contributing factor to various diseases, including aging and cardiovascular diseases. N-6-Trifluoroacetyl-L-Lysine has been found to possess antioxidant properties, which can help neutralize reactive oxygen species and protect cells from oxidative damage. This makes it a potential therapeutic agent for conditions associated with oxidative stress.

Neuroprotective Effects

The nervous system is highly susceptible to oxidative stress and inflammation, which can lead to neurodegenerative diseases such as Alzheimer's and Parkinson's. N-6-Trifluoroacetyl-L-Lysine has shown neuroprotective effects, which may be attributed to its antioxidant and anti-inflammatory properties. This suggests that it could be a valuable therapeutic agent for neurodegenerative diseases.

Conclusion

In conclusion, N-6-Trifluoroacetyl-L-Lysine, with its CAS number 10009-20-8, is a promising compound with a wide range of health benefits. Its role in protein synthesis, immune system support, potential applications in cancer treatment, antioxidant properties, and neuroprotective effects make it a valuable candidate for further research and development. As our understanding of its mechanisms and applications continues to grow, N-6-Trifluoroacetyl-L-Lysine may play a significant role in improving human health.

Keywords

N-6-Trifluoroacetyl-L-Lysine, CAS 10009-20-8, protein synthesis, immune system, cancer treatment, antioxidant, neuroprotective effects

Feel free to contact us
Contact Form Demo

Request A Free Quote

Contact Form Demo
envelope
en_AUEnglish (Australia)